Put companies on watchlist
Cannovum Cannabis AG
ISIN: DE000A37FUP2
WKN: A37FUP
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

EN GIF 300X250

Cannovum Cannabis AG · ISIN: DE000A37FUP2 · EQS - adhoc news (9 News)
Country: Germany · Primary market: Germany · EQS NID: 1917083
04 June 2024 10:20AM

Cash capital increase from authorized capital with subscription rights


EQS-Ad-hoc: Cannovum Cannabis AG / Key word(s): Corporate Action
Cannovum Cannabis AG: Cash capital increase from authorized capital with subscription rights

04-Jun-2024 / 10:20 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Art. 17 MAR 04.06.2024

 

Cannovum Cannabis AG: Cash capital increase from authorized capital with subscription rights

The Management Board of Cannovum Cannabis AG (stock exchanges Frankfurt, Xetra, Düsseldorf, Munich, Hamburg, Berlin, Tradegate, gettex: ISIN DE000A2LQU21) today resolved to carry out a capital increase from the authorized capital by issuing 888,900 new shares on the basis of the authorization of the Annual General Meeting on 13.11.2020.

The Executive Board has decided to grant the shareholders subscription rights by offering the new shares exclusively to the current shareholders of the company at a ratio of 8:5 at a subscription price of EUR 1.00 per share in accordance with Section 186 (5) AktG. The close of business today will be set as the time of proof for the subscription right.

It is planned that the offer to shareholders will be made without a prospectus. The subscription period is fourteen days and will be announced after approval and publication of the securities information sheet.

The proceeds from this cash capital increase will be used to reduce liabilities and finance ongoing business operations.

 

Contact:

Klaus Madzia

Management Board

Cannovum Cannabis AG

email: klaus.madzia@cannovum.com

 

About Cannovum Cannabis AG:

Cannovum AG (www.cannovum.de, www.cannovum.com) is the first German cannabis company to be traded on the stock exchange. The shares are traded on the Frankfurt/Xetra, Düsseldorf, Munich, Berlin, Hamburg and gettex stock exchanges.



End of Inside Information

04-Jun-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Cannovum Cannabis AG
Stresemannstrasse 23
10963 Berlin
Germany
Phone: 0178 5811701
E-mail: klaus.madzia@cannovum.com
Internet: www.cannovum.com
ISIN: DE000A37FUP2
WKN: A37FUP
Listed: Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt, Hamburg, Munich, Tradegate Exchange
EQS News ID: 1917083

 
End of Announcement EQS News Service

1917083  04-Jun-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1917083&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f
Visual performance / price development - Cannovum Cannabis AG
Smart analysis and research tools can be found here.

This publication was provided by our content partner EQS3.

EQS Newswire
via EQS - Newsfeed
EQS Group AG ©2024
(DGAP)
Contact:
Karlstraße 47 D-80333 München
+49 (0) 89 444 430-000

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S

The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.


The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.

If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.

For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.


1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.